Pure Financial Advisors’s Integra LifeSciences IART Stock Holding History

Pure Financial Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$193K	Buy	10,764 +38	+0.4%	+$531	﹤0.01%	616
2026 Q1	$101K	Sell	10,726 -79	-0.7%	-$867	﹤0.01%	562
2025 Q4	$134K	Buy	10,805 +83	+0.8%	+$1.1K	﹤0.01%	526
2025 Q3	$154K	Buy	10,722 +96	+0.9%	+$1.31K	﹤0.01%	485
2025 Q2	$130K	Hold	10,626	–	–	﹤0.01%	463
2025 Q1	$234K	Hold	10,626	–	–	﹤0.01%	352
2024 Q4	$241K	Hold	10,626	–	–	0.01%	311
2024 Q3	$193K	Sell	10,626 -83	-0.8%	-$1.92K	﹤0.01%	320
2024 Q2	$312K	Buy	10,709 +83	+0.8%	+$2.46K	0.01%	252
2024 Q1	$377K	Hold	10,626	–	–	0.01%	232
2023 Q4	$463K	Hold	10,626	–	–	0.02%	198
2023 Q3	$406K	Hold	10,626	–	–	0.02%	186
2023 Q2	$437K	Sell	10,626 -45	-0.4%	-$2.17K	0.02%	174
2023 Q1	$613K	Hold	10,671	–	–	0.03%	150
2022 Q4	$598K	Hold	10,671	–	–	0.03%	146
2022 Q3	$452K	Sell	10,671 -2	-0%	-$102	0.03%	154
2022 Q2	$577K	Hold	10,673	–	–	0.04%	141
2022 Q1	$686K	Hold	10,673	–	–	0.03%	132
2021 Q4	$715K	Hold	10,673	–	–	0.04%	117
2021 Q3	$731K	Sell	10,673 -51	-0.5%	-$3.6K	0.06%	110
2021 Q2	$732K	Hold	10,724	–	–	0.06%	107
2021 Q1	$741K	Hold	10,724	–	–	0.07%	97
2020 Q4	$696K	Hold	10,724	–	–	0.08%	102
2020 Q3	$506K	Hold	10,724	–	–	0.07%	103
2020 Q2	$504K	Sell	10,724 -57	-0.5%	-$2.8K	0.08%	93
2020 Q1	$482K	Hold	10,781	–	–	0.08%	91
2019 Q4	$628K	Hold	10,781	–	–	0.11%	87
2019 Q3	$648K	Hold	10,781	–	–	0.12%	81
2019 Q2	$602K	Hold	10,781	–	–	0.11%	82
2019 Q1	$601K	Hold	10,781	–	–	0.11%	80
2018 Q4	$486K	Hold	10,781	–	–	0.1%	87
2018 Q3	$710K	Buy	+10,781	New	+$670K	0.16%	71
2017 Q4	–	Sell	-10,860	Closed	-$548K	–	36
2017 Q3	$548K	Sell	10,860 -38	-0.3%	-$1.95K	0.14%	64
2017 Q2	$594K	Hold	10,898	–	–	0.16%	62
2017 Q1	$459K	Hold	10,898	–	–	0.13%	69
2016 Q4	$467K	Buy	10,898 +38	+0.3%	+$1.54K	0.14%	62
2016 Q3	$448K	Hold	10,860	–	–	0.14%	64
2016 Q2	$433K	Hold	10,860	–	–	0.15%	60
2016 Q1	$367K	Hold	10,860	–	–	0.13%	66
2015 Q4	$368K	Sell	10,860 -52	-0.5%	-$1.63K	0.16%	50
2015 Q3	$325K	Sell	10,912 -2,436	-18%	-$76.2K	0.15%	48
2015 Q2	$368K	Hold	13,348	–	–	0.18%	48
2015 Q1	$336K	Hold	13,348	–	–	0.11%	44
2014 Q4	$296K	Sell	13,348 -98	-0.7%	-$1.99K	0.1%	48
2014 Q3	$273K	Sell	13,446 -5	-0%	-$100	0.1%	46
2014 Q2	$259K	Buy	13,451 +5	+0%	+$93	0.1%	50
2014 Q1	$248K	Buy	+13,446	New	+$259K	0.1%	47
2013 Q4	–	Sell	-13,446	Closed	-$221K	–	51
2013 Q3	$221K	Hold	13,446	–	–	0.11%	49
2013 Q2	$201K	Buy	+13,446	New	+$197K	0.11%	47

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Pure Financial Advisors's IART Position: Q2 2026 in Review

Pure Financial Advisors increased its Integra LifeSciences (IART) stake by 0.35% in Q2 2026, buying an estimated $531 and bringing the position to 10,764 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Pure Financial Advisors first reported a position in IART in Q2 2013 and has held it in 49 quarters since. The position peaked at $741K in Q1 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Pure Financial Advisors held 10,764 shares of Integra LifeSciences worth $193K as of Q2 2026.
Pure Financial Advisors bought 38 Integra LifeSciences shares in Q2 2026, an estimated $531.
Integra LifeSciences made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #616 holding.
Pure Financial Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 49 quarters since.
Pure Financial Advisors's Integra LifeSciences position peaked at $741K in Q1 2021.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.